Transferrin neutralization of amyloid β 25-35 cytotoxicity

Clinica Chimica Acta

Volumn 350, Issue 1-2, 2004, Pages 129-136

  Giunta, Sergio ^a   Galeazzi, Roberta ^a   Valli, M Beatrice ^a   Corder, Elizabeth H ^b   Galeazzi, Luciano ^a  

^a Osp Geriatrico INRCA Via Della M   (Italy)

^b DUKE UNIVERSITY   (United States)

Author keywords

Alzheimer pathogenesis; Amyloid ; Red blood cells; Transferrin

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[25-35]; APOLIPOPROTEIN E; CONGO RED; TRANSFERRIN;

ADULT; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CONGO RED; DRUG INTERACTIONS; ERYTHROCYTES; HEMOLYSIS; HUMANS; PEPTIDE FRAGMENTS; SPECTROPHOTOMETRY; TRANSFERRIN;

EID: 7644227597     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.07.025     Document Type: Article

References (35)

1. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
2. G. Casadeus, M.A. Smith, X. Zhu, G. Aliev, A.D. Cash, and K. Honda Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species J. Alzheimer's Dis. 6 2004 165 169
3. A. Monji, H. Utsumi, T. Ueda, T. Imoto, I. Yoshida, and S. Hashioka Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides Life Sci. 70 2002 833 841
4. A. Monji, H. Utsumi, T. Ueda, T. Imoto, I. Yoshida, and S. Hashioka The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by peptides J. Neurochem. 77 2001 1425 1432
5. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, and K.H. Grzeschik The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 735
6. B.A. Yankner, L. Duffy, and D. Kirshner Neurotrophic and neurotoxic effect of amyloid β protein: reversal by tachykinin neuropeptides Science 250 1990 279 282
7. M.P. Mattson, J.G. Bergley, R.J. Mark, and K. Furukawa Aβ 25-35 induces rapid lysis of red blood cells: contrast with Aβ 1-42 and examination of underlying mechanisms Brain Res. 771 1997 147 153
8. L. Galeazzi, E.H. Corder, R. Galeazzi, T. Casoli, M.B. Valli, and S. Giunta In vitro apolipoprotein E protects human red blood cells against lysis induced by amyloid-beta (Aβ) fragment 25-35 Amyloid: J. Protein Folding Disord. 9 2002 103 107
9. T. Harkany, I. Abraham, C. Konya, C. Nyakas, M. Zarandi, and B. Penke Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy Rev. Neurosci. 11 2000 329 382
10. 25-35-induced lysis more effectively than ApoE NeuroReport 13 2002 2149 2154
11. H.A. Hueber, and C.A. Finch The physiology of transferrin receptors Physiol. Rev. 67 1987 520 582
12. A.R. Aldred, P.W. Dickson, P.D. Marley, and G. Schreiber Distribution of transferrin synthesis in brain and other tissue J. Biol. Chem. 262 1987 5293 5297
13. W.A. Jefferies, M.R. Brandon, S.U. Hunt, A.F. Williams, K.C. Gatter, and D.Y. Mason Transferrin receptor on endothelium of brain capillaries Nature 312 1984 162 163
14. B. Bloch, T. Popovici, M.J. Levin, D. Tuil, and A. Kahn Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry Proc. Natl. Acad. Sci. U. S. A. 82 1985 6706 6710
15. A. Takeda Significance of transferrin in iron delivery to the brain J. Health Sci. 47 2001 520 524
16. G.A. de Arriba Zerpa, M.C. Saleh, P.M. Fernandez, F. Guillou, A. Espinosa de los Monteros, and J. de Vellis Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line J. Neurosci. Res. 61 2000 388 395
17. M.W.B. Bradbury Transport of iron in the blood-brain-cerebrospinal fluid system J. Neurochem. 69 1997 443 454
18. T. Moos, and E.H. Morgan Evidence for low molecular weight non-transferrin-bound iron in rat brain and cerebrospinal fluid J. Neurosci. Res. 54 1998 486 494
19. D.C. Lipscomb, L.G. Gorman, R.J. Traystman, and P.D. Hurn Low molecular weight iron in cerebral ischemic acidosis in vivo Stroke 29 1998 487 492
20. D.A. Loeffler, J.R. Connor, P.L. Juneau, B.S. Snyder, L. Kanaley, and A.J. De Maggio Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain region J. Neurochem. 65 1995 710 716
21. R. Motter, C. Vigo-Pelfrey, D. Kholodenko, R. Barbour, K. Johnson-Wood, and D. Galasko Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's Disease Ann. Neurol. 38 1995 643 648
22. K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, and J.F. Wu A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 91 1994 3270 3274
23. W.E. Klunk, J.W. Pettegrew, and D.J. Abraham Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation J. Histochem. Cytochem. 37 1989 1273 1281
24. S.J. Wood, B. Maleef, T. Hart, and R. Wetzel Physical morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J. Mol. Biol. 256 1996 870 877
25. J.Q. Trojanowski Tauists, Baptists, Syners, Apostates, and new data Ann. Neurol. 52 2002 263 265
26. C.W. Olanow A radical hypothesis for neurodegeneration Trends Neurosci. 16 1993 439 444
27. P. Fisher, M.E. Gotz, W. Danielczyk, W. Gsell, and P. Riederer Blood transferrin and ferritin in Alzheimer's disease Life Sci. 60 1997 2273 2278
28. F. Magri, B. Muzzoni, L. Cravello, M. Fioravanti, L. Busconi, and D. Camozzi Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers Metabolism 51 2002 105 109
29. C. Mias, P. Jurscik, T. Massoni, M. Sadurni, J.J. Aguila, and R. Sola Assessment of the nutritional status of elderly patients treated at a home-hospital unit Nutr. Hosp. 18 2003 6 14
30. F. Magri, A. Borza, S. del Vecchio, S. Chytiris, G. Cuzzoni, and L. Busconi Nutritional assessment of demented patients: a descriptive study Aging Clin. Exp. Res. 15 2003 148 153
31. R.N. Kalaria The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease Ann. N.Y. Acad. Sci. 893 1999 113 125
32. G.M. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood, and M.A. Smith Iron: a pathological mediator of Alzheimer disease? Dev. Neurosci. 24 2002 184 187
33. J.R. Connor, S.L. Menzies, S.M. St. Martin, and E.J. Mufson A histochemical study of iron, transferrin and ferritin in Alzheimer's disease brains J. Neurosci. Res. 31 1992 75 83
34. V.V. Trubetskaya, M.Yu. Stepanichev, M.V. Onufriev, N.A. Lazareva, V.A. Markevich, and N.V. Gulyaeva Administration of aggregated Beta-amyloid peptide (25-35) induces changes in long term potentiation in the hippocampus in vivo Neurosci. Behav. Physiol. 33 2003 95 98
35. R. Jayakumar, J.W. Kusiak, F.J. Chrest, A.A. Demehin, J. Murali, and R.P. Wersto Red cell perturbation by amyloid beta-protein Biochim. Biophys. Acta 1622 2003 20 28